Alliance Pharma (LON:APH) Share Price Passes Above 200 Day Moving Average – Here’s What Happened

Alliance Pharma plc (LON:APH) passed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of GBX 52.26 ($0.68) and traded as high as GBX 64.50 ($0.84). Alliance Pharma shares last traded at GBX 64.20 ($0.83), with a volume of 476,889 shares trading hands.

Analyst Ratings Changes

Separately, Berenberg Bank cut Alliance Pharma to a “hold” rating and reduced their target price for the stock from GBX 7,000 ($90.90) to GBX 6,250 ($81.16) in a research report on Wednesday, January 29th.

Alliance Pharma Trading Up 0.2 %

The company has a debt-to-equity ratio of 46.27, a quick ratio of 1.42 and a current ratio of 2.93. The company’s 50-day moving average is GBX 62.39 and its 200-day moving average is GBX 52.26. The firm has a market cap of £347.61 million, a price-to-earnings ratio of -10.35, a P/E/G ratio of 1.04 and a beta of 0.67.

About Alliance Pharma

Alliance Pharma plc operates as a pharmaceutical company in Europe, the Middle East, Africa, the Asia Pacific, China, and the Americas. The company acquires, markets, and distributes consumer healthcare and prescription medicine products. The company also offers medicines, medical devices, food supplements, and cosmetics.